Valerie Poinsot - Boiron SA Deputy CEO, Director of Development

BOIRF Stock  USD 36.81  0.00  0.00%   

CEO

Ms. Valerie Poinsot has served as Chief Executive Officer and Director at Boiron SA since January 1, 2019. She is Director of the company as of May 22, 2014. She previously served as Deputy Chief Executive Officer and Development Director of the company as of July 1, 2011. She also works as Chairman of the Board and Chief Executive Officer of Les Editions Similiaa and Director of Boiron USA, Boiron Medicamentos Homeopaticos, Boiron Canada as well as Chairwoman of FYTEXIA, among others. since 2019.
Age 49
Tenure 5 years
Phone33 4 78 45 61 00
Webhttps://www.boiron.fr

Boiron SA Management Efficiency

The company has return on total asset (ROA) of 0.0637 % which means that it generated a profit of $0.0637 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0987 %, meaning that it generated $0.0987 on every $100 dollars invested by stockholders. Boiron SA's management efficiency ratios could be used to measure how well Boiron SA manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.35 M in total debt with debt to equity ratio (D/E) of 0.05, which may suggest the company is not taking enough advantage from borrowing. Boiron SA has a current ratio of 2.84, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Boiron SA until it has trouble settling it off, either with new capital or with free cash flow. So, Boiron SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Boiron SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Boiron to invest in growth at high rates of return. When we think about Boiron SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 9 records

CEO Age

Terry BoothAurora Cannabis
54
Brendan KennedyTilray Inc
44
Miguel MartinAurora Cannabis
51
Irwin SimonTilray Inc
66
Paul ThomsonAurora Cannabis
N/A
Mark ZekulinCanopy Growth Corp
N/A
Joseph LusardiCuraleaf Holdings
49
David KleinCanopy Growth Corp
60
Michael JDCronos Group
37
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. Boiron SA was founded in 1932 and is headquartered in Messimy, France. BOIRON operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2794 people. Boiron SA [BOIRF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Boiron SA Leadership Team

Elected by the shareholders, the Boiron SA's board of directors comprises two types of representatives: Boiron SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boiron. The board's role is to monitor Boiron SA's management team and ensure that shareholders' interests are well served. Boiron SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boiron SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Philippe Montant, Deputy CEO, Director of Administration and Finance
Valrie LorentzPoinsot, GM Director
Thierry Boiron, Chairman of the Board of Directors, Director
Eric Lambert, S Gen
Michel Bouissou, Independent Director
Michele Boiron, Director
Franois Marchal, Independent Director
Gregory Walter, Non-Executive Director, Representative of shareholder employees
Jacky Abecassis, Director
Philippe Gouret, Chief Pharmacist, Director of Production and Distribution and Deputy General Manager
Valerie Poinsot, Deputy CEO, Director of Development
JeanChristophe Bayssat, Deputy CEO, Chief Pharmacist, Pharmaceutical Development Director
Stephanie Chesnot, Director
Bruno Grange, Financial Controller, Director and Member of Compensation Committee
Fabrice Rey, Group Treasurer
Virginie Heurtaut, Non-Executive Director
Christine Boutin, Non-Executive Director - Employees Representative
Christine BoyerBoiron, Director
Christine Place, Deputy Mang
JeanPierre Boyer, Director
Patrice Varraut, Director Operations
Christian Boiron, General Manager and Director

Boiron Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Boiron SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Boiron SA

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boiron SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boiron SA will appreciate offsetting losses from the drop in the long position's value.

Moving together with Boiron Pink Sheet

  0.61TKPHF Takeda PharmaceuticalPairCorr

Moving against Boiron Pink Sheet

  0.82TEVA Teva PharmaceuticalPairCorr
The ability to find closely correlated positions to Boiron SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boiron SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boiron SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boiron SA to buy it.
The correlation of Boiron SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boiron SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boiron SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boiron SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boiron SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Boiron Pink Sheet analysis

When running Boiron SA's price analysis, check to measure Boiron SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boiron SA is operating at the current time. Most of Boiron SA's value examination focuses on studying past and present price action to predict the probability of Boiron SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boiron SA's price. Additionally, you may evaluate how the addition of Boiron SA to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Please note, there is a significant difference between Boiron SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boiron SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boiron SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.